News
Every day, manufacturers continue to develop new, life-saving cancer treatments, and breakthroughs in oncology promise ... Development-phase companies need to establish distribution networks ...
3d
Pharmaceutical Technology on MSNNovartis commits $23bn to US manufacturing amid tariff threatsNovartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...
12d
Pharmaceutical Technology on MSNAstellas Pharma and JFCR partner for oncology researchThe agreement stipulates that projects will be co-selected, drawing on shared interests and areas of expertise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results